N
PACB icon

Numerai’s Pacific Biosciences PACB Stock Holding History

Numerai’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
+621,469
New +$904K 0.09% 388
2024
Q2 		– Sell
-25,769
Closed -$96.6K – 401
2024
Q1 		$96.6K Buy
+25,769
New +$151K 0.04% 242
2023
Q4 		– Sell
-186,635
Closed -$1.56M – 293
2023
Q3 		$1.56M Sell
186,635
-104,482
-36% -$1.19M 0.52% 68
2023
Q2 		$3.87M Buy
+291,117
New +$3.54M 0.79% 47

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Numerai's PACB Position: Q2 2026 in Review

Numerai opened a new position in Pacific Biosciences (PACB) in Q2 2026: 621,469 shares worth $1.04M. The stake represents 0.09% of the portfolio and ranks #388 among its holdings. This is a return to the name: Numerai previously reported a position in PACB as recently as Q1 2024.

Numerai first reported a position in PACB in Q2 2023 and has held it in 4 quarters since. The position peaked at $3.87M in Q2 2023. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Numerai held 621,469 shares of Pacific Biosciences worth $1.04M as of Q2 2026.
  • Pacific Biosciences was a new Numerai position in Q2 2026.
  • Pacific Biosciences made up 0.09% of Numerai's portfolio in Q2 2026, its #388 holding.
  • Numerai first reported a position in Pacific Biosciences in Q2 2023 and has held it in 4 quarters since.
  • Numerai's Pacific Biosciences position peaked at $3.87M in Q2 2023.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Numerai's 13F filing for Q2 2026, filed 14 Aug 2026.